How to Assess Strategic Fit Across an M&A Pipeline

Consider a leadership team reviewing four acquisition targets. One strengthens the existing business. Another opens a new market. Athird brings a missing capability. The fourth offers a position in an emerging business model.

Each has a persuasive presentation. Each could consume the capital, integration capacity, or executive attention needed for the others.

Which should move forward?

That question requires more than four independent deal reviews to ensure that there is financial upside. An M&A target assessment should establish what each acquisition contributes to the strategic direction of the acquiring company, what evidence supports that contribution, and how pursuing it changes the choices the leadership team can make.

An attractive business is not automatically the right acquisition. CFA Institute’s guidance on capital allocation makes the underlying distinction clear: an investment can appear profitable on its own yet compare poorly with alternatives or the organization’s overall strategy.

The practical question is therefore not simply, “Would we like to own this company?”

It is, “What would this acquisition enable, and what would committing to it prevent us from doing?”

Define the Acquisition Thesis and Success Measures First

Start by choosing measures tied to the growth outcome, before evaluating available targets.

For an established business, assess incremental cash generation and net present value (NPV) after acquisition and implementation costs. For an adjacency, add evidence of customer adoption and the cost of serving the new market. For an uncertain business model, specify learning milestones, further funding requirements, and conditions for stopping.

These are complementary tests, not exemptions from financial discipline. NPV estimates value creation; internal rate of return, or IRR, estimates a return rate under specified assumptions. Neither establishes strategic fit by itself.

Write the acquisition thesis in one sentence:

“We are considering this acquisition to achieve [strategic outcome], using [specific advantage], with success demonstrated by [measurable evidence] within [time horizon].”

Replace “increase scale” with something concrete, such as gaining service coverage needed to win a defined customer segment. Then explain why this buyer can deliver that outcome better than the target independently.

Set the boundaries alongside the ambition: available capital, acceptable downside, management capacity, and the time available to produce results. For a private equity-backed platform, make the expected ownership period explicit rather than assume every benefit arrives before exit.

Finally, compare acquisition with building internally, partnering, licensing, and deferring. Use the same strategic objective for each alternative. Buying a company is a means of executing the strategy, not the strategy itself.

Categorize Targets by Their Primary Strategic Role

A useful growth-opportunity lens distinguishes Core Growth, Market Adjacencies, Product Adjacencies, and Disruptive Potential. These describe growth opportunities. The four acquisition roles below are a practical application to deal assessment, not a replacement for those growth pools.

Core Extensions: Test the Remaining Growth Opportunity

Examine whether the target serves customers with attractive continuing demand. Test achievable efficiencies, customer retention, and service quality. Familiarity should not excuse weak economics or an acquisition that merely adds exposure to a declining segment.

Market Adjacencies: Test Transferability

Identify the advantage that should travel with the business: technical knowledge, distribution, customer relationships, or another specific strength. Then investigate what changes in the new setting. A similar product does not establish that buyers, channels, or service requirements are similar.

Capability Acquisitions: Test Deployment

Specify where the capability will be used, who will adopt it, and what complementary resources it needs. A capability acquisition might strengthen Core Growth now and enable a Product Adjacency later. Record both, but identify the primary reason for buying.

Disruptive Options: Test the Business Model

Do not equate “disruptive” with advanced technology or rapid growth. The Christensen Institute describes disruption as a process in which simpler, more accessible offerings gain a foothold and move upmarket. Its assessment tests include serving nonconsumers or overserved customers and having a viable business model.

A broader practical lens is whether customers accept significant trade-offs to achieve a different outcome. Treat that as a hypothesis to investigate, not proof that every unconventional target is disruptive.

Calling a target an option does not make a full acquisition reversible. Separate the cost of learning from the cost of ownership.

Assign one primary acquisition role and secondary tags where needed. That keeps overlapping benefits visible without allowing an uncertain thesis to become “a little of everything.”

Use a Common M&A Target Assessment Structure

Use two layers: prerequisites and comparative assessment.

First, identify conditions that could invalidate the transaction. Ask the relevant specialists to flag financing constraints, legal or regulatory feasibility issues, ownership questions, and critical dependencies. An open issue can remain under investigation, but give it an owner and a resolution deadline before the relevant commitment.

Then compare targets through a consistent set of questions:

Keep the structure consistent while changing the required evidence. A core extension might need contract-level retention analysis. An adjacency needs evidence from the new customer group. A capability target needs a deployment test. A disruptive option needs evidence that customers accept the proposed trade-offs.

Avoid collapsing everything into one score. “Strong strategic contribution, weak evidence” is more useful than an unexplained 4 out of 5. Distinguish an early-stage information gap from evidence that the thesis is wrong.

Also separate strategic fit, investment attractiveness, and readiness to proceed. These are different judgments.

In his work on acquisition valuation, Aswath Damodaran distinguishes standalone value from control improvements and synergy. Paying away the anticipated benefits can leave the buyer without a value gain, even when the combination makes strategic sense.

Build an explicit bridge from standalone cash flows to buyer-specific benefits, then account for acquisition price, implementation costs, and timing. Include required technology and compliance investment rather than treating current earnings as the whole picture. Plan for investments needed to preserve operating performance.

Evaluate the Pipeline as a Portfolio of Choices

The individual assessments are inputs. The next task is to compare combinations and sequences the organization could realistically execute.

Start with a practical portfolio question:

Which set of opportunities best advances the strategy within our capital, risk, and execution limits?

Compare Total Resource Demands

Map each target’s purchase funding, integration investment, follow-on capital, and demands on named leaders. Place these alongside existing commitments and organic growth initiatives.

If two acquisitions require the same operations leader during the same period, do not assume both integration plans remain achievable unchanged. Model sequencing, additional capacity, and the cost of postponing another priority.

Identify Dependencies and Overlap

Ask whether one target provides a capability needed to create value from another. Also ask whether buying one removes the need for the other.

Keep a shared record of synergy assumptions. Do not count the same customer opportunity in several acquisition cases and then add every forecast together. CFA Institute’s capital-allocation principles explicitly call for avoiding double counting and including effects on the rest of the business, including lost sales from existing products.

Damodaran’s valuation approach also asks what form synergy takes and when it affects cash flows. Apply that discipline to combinations, not just individual deals.

Test Shared Exposure and Timing

Run a common downside scenario across the shortlisted combinations. What happens if a major customer segment weakens, adoption takes longer, or integration milestones slip?

Use the discussion of growth strategies in uncertain times as a starting point for matching investment decisions to evidence, time horizons, and explicit reassessment triggers.

Keep availability separate from attractiveness. A target in the pipeline is not an asset under your control. Test what remains viable if one deal closes late or not at all. Do not assume a partnership grants a future acquisition right unless you actually negotiate it.

A coherent portfolio does not require a target in every category. It may justify concentrating on the core, pursuing a specific adjacency, or making no acquisition now.

For private equity teams, apply this operating assessment to the platform’s pipeline. Review fund-level capital allocation and concentration separately; do not assume operating synergies among unrelated holdings.

Match the Integration Approach to the Acquisition Thesis

Before advancing a target, outline what to integrate, what to preserve, and who owns value creation.

In Harvard Business Review’s The New M&A Playbook, Clayton Christensen and his coauthors distinguish acquisitions that strengthen an existing business model from those that use the acquired model as a new growth platform. The rationale changes what the buyer needs to preserve or combine.

The Christensen Institute’s Business Model Theory offers a useful assessment lens: customer value proposition, resources, processes, and profit formula or priorities. Examine compatibility across those elements rather than assuming a common owner requires identical operations.

For a capability acquisition, investigate whether the advantage resides in individual assets or in a team’s established ways of working. Test whether moving the people or changing incentives would weaken deployment.

For a different business model, consider whether you need separate processes, measures, and decision rights. Autonomy should still include accountability, funding limits, and agreed evidence milestones.

The practical test is straightforward: Could our integration plan undermine what makes this target valuable?

Put the answer into the acquisition case before approval, together with the resources needed to protect the thesis.

Build a Pipeline That Expresses the Strategy

Make M&A target assessment repeatable. For every active target, maintain a concise record of its strategic role, evidence-backed thesis, economic case, resource demands, accountable owner, next decision, and stopping conditions.

Revisit that record when evidence changes, another transaction advances, or the operating business needs resources previously allocated to acquisitions. Carry the original measures into post-close reviews so the organization can compare the acquisition thesis with results and improve future decisions.

At each review, ask what the team has learned that changes the choice. A longer target list is not necessarily progress. Eliminating a weak thesis, identifying a dependency, or choosing a better alternative can be a valuable outcome.

This is consistent with Leverage Co.’s Growth Systems approach, which emphasizes structured governance, learning, and prioritization. Apply that discipline to the acquisition pipeline rather than manage every opportunity as an isolated transaction.

The goal is not to acquire the most attractive collection of companies. It is to choose acquisitions that, together, make the strategy more achievable.